A group of people talking

Your first step to partnering with us

Contact us

Our partnering team

Our partnering team is integrated and designed to incorporate early input from experts in business development, R&D and commercial. Our team has extensive experience in identifying synergistic opportunities which are complementary to our capabilities and facilitating successful collaborations through effective alliance management.

Our dedicated business development teams are responsible for scouting for late-stage opportunities as well as facilitating the transactional aspects of the deal. Our R&D strategy teams are tasked with sourcing early stage innovation from both inside and outside the organisation, and are involved in the evaluation process of all deals from day one.

If you want to discuss how we can help you to leverage your regional commercial capabilities, please contact our regional and corporate business development team. Our Venture Capital Interaction Team (VCIT) is focused on proactively interacting with VCs.

Partnering leadership team

Areas of interest

Cardiovascular & Metabolic Diseases

Small molecule business developmentR&D Strategy HeadBiologics business development
Christoph Pittius

VP SPBD, CVGI

James Hall

VP Strategy, CVGI

Eric Victory

VP, Corporate Development

Oncology 

Small molecule business developmentR&D Strategy HeadBiologics business development

Tim Herpin

VP SPBD, Oncology and STL

Detlev Biniszkiewicz

VP Strategy, Oncology

Tracey Vetterick

Director, Business Development

Respiratory, Inflammation & Autoimmune

Small molecule business developmentR&D Strategy HeadBiologics business development

Joanne Kelly

VP SPBD, R&I and New Opportunities

Rose Maciewicz

VP Strategy, R&I

Jennifer Ma

Associate Director, Business Development

Infection

Small molecule business developmentR&D Strategy HeadBiologics business development

Karen Gallant

VP SPBD, Infection and PHB

Jacques Dumas

VP Strategy, Infection

Jennifer Ma

Associate Director, Business Development

Neuroscience

Small molecule business developmentR&D Strategy HeadBiologics business development

Kumar Srinivasan

VP New Business Development, Neuroscience

Frank Yocca

VP Strategy, Neuroscience

Christina Griffin

Senior Manager, Business Development

New opportunities

Small molecule business developmentR&D Strategy HeadBiologics business development

Mark Rogers

Executive Business Development Director
& Venture Capital Co-ordinator

Robert Ward

VP Strategy, New Opportunities

John Trainer

Vice-President, Corporate Business Development

Personalised Healthcare & Biomarkers (PHB)

Small molecule business developmentR&D Strategy HeadBiologics business development

Cecilia Schott

Executive Business Development Director, Personalised Healthcare

Glenn Miller

VP Strategy, PHB

John Trainer

Senior Director, Business Development

Science & Technology (STL)

Small molecule business developmentR&D Strategy HeadBiologics business development

Campbell Wilson

Executive Business Development Director, STL

n/a

John Trainer

Senior Director, Business Development

Regional and corporate business development

Russell Gantt

VP Regional and Corporate Business Development

Russell.Gantt@astrazeneca.com

Denise E Goode

Executive Director, Regional & Corporate Business Development

Denise.Goode@astrazeneca.com

Jeanette Evans

Executive Director, Regional & Corporate Business Development

Jeanette.Evans@astrazeneca.com

Mahmood Ladha

Executive Director, Regional & Corporate Business Development

Mahmood.Ladha2@astrazeneca.com

 

Europe, Middle East, Africa

Geoff Collett
Regional Business Development Director

Geoff.Collett@astrazeneca.com

USA

Will Mongon
Executive Director, US Business development

Will.mongon@astrazeneca.com
 

Asia Pacific

Augustine Yee
Regional Business Development Director

Augustine.Yee@astrazeneca.com

Japan

Russell Gantt
VP Regional and Corporate Business Development

Russell.Gantt@astrazeneca.com

General Enquiries

Chris Yochim
Director External Relations

Chris.Yochim@astrazeneca.com

Venture Capital enquiries

AreaKey Contact
All enquiries

Mark Rogers
Executive Business Development Director & Venture Capital Co-ordinator

Mark.V.Rogers@astrazeneca.com

Download our contact details

Download

Download the details of our partnering leadership team.


Download our brochure

Download your comprehensive guide to partnering with us.